American Society of Breast Surgeons website. Consensus guideline on concordance assessment of image-guided breast biopsies and management of borderline or high-risk lesions. www.breastsurgeons.org/docs/ statements/Consensus-Guideline-on-Concordance-Assessment-of-ImageGuided-Breast-Biopsies.pdf. Accessed April 4, 2023.

Lewin AA, Mercado CL (2020) Atypical ductal hyperplasia and lobular neoplasia: update and easing of guidelines. AJR Am J Roentgenol 214(2):265–275. https://doi.org/10.2214/AJR.19.21991

Article  PubMed  Google Scholar 

Falomo E, Adejumo C, Carson KA, Harvey S, Mullen L, Myers K (2019) Variability in the management recommendations given for high-risk breast lesions detected on image-guided core needle biopsy at U.S. academic institutions. Curr Probl Diagn Radiol 48(5):462–466. https://doi.org/10.1067/j.cpradiol.2018.06.004

Article  PubMed  Google Scholar 

Krishnamurthy S, Bevers T, Kuerer HM, Smith B, Yang WT (2017) Paradigm shifts in breast care delivery: impact of imaging in a multidisciplinary environment. AJR Am J Roentgenol 208(2):248–255. https://doi.org/10.2214/AJR.16.17130

Article  PubMed  Google Scholar 

Sokolova A, Lakhani SR (2021) Lobular carcinoma in situ: diagnostic criteria and molecular correlates. Mod Pathol 34(Suppl 1):8–14. https://doi.org/10.1038/s41379-020-00689-3

Article  PubMed  Google Scholar 

Racz JM, Carter JM, Degnim AC (2017) Lobular neoplasia and atypical ductal hyperplasia on core biopsy: current surgical management recommendations. Ann Surg Oncol 24(10):2848–2854. https://doi.org/10.1245/s10434-017-5978-0

Article  PubMed  Google Scholar 

Boland PA, Dunne EC, Kovanaite A, Stokes M, Kell MR, Barry JM, Kennedy M, Flanagan F, Walsh SM (2020) Lobular intraepithelial neoplasia: outcomes and optimal management. Breast J 26(12):2383–2390. https://doi.org/10.1111/tbj.14117

Article  PubMed  Google Scholar 

Middleton LP, Sneige N, Coyne R, Shen Y, Dong W, Dempsey P, Bevers TB (2014) Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting. Cancer Med 3(3):492–499. https://doi.org/10.1002/cam4.223

Article  PubMed  PubMed Central  Google Scholar 

Page DL, Schuyler PA, Dupont WD, Jensen RA, Plummer WD Jr, Simpson JF (2003) Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361(9352):125–129. https://doi.org/10.1016/S0140-6736(03)12230-1

Article  PubMed  Google Scholar 

Calle C, Kuba MG, Brogi E (2020) Non-invasive lobular neoplasia of the breast: morphologic features, clinical presentation, and management dilemmas. Breast J 26(6):1148–1155. https://doi.org/10.1111/tbj.13857

Article  PubMed  Google Scholar 

Chikarmane SA, Harrison BT, Giess CS, Pinkney DM, Gombos EC (2021) Lobular neoplasia detected at MRI-guided biopsy: imaging findings and outcomes. Clin Imaging 78:171–178. https://doi.org/10.1016/j.clinimag.2021.03.026

Article  PubMed  Google Scholar 

Stein LF, Zisman G, Rapelyea JA, Schwartz AM, Abell B, Brem RF (2005) Lobular carcinoma in situ of the breast presenting as a mass. AJR Am J Roentgenol 184(6):1799–1801. https://doi.org/10.2214/ajr.184.6.01841799

Article  PubMed  Google Scholar 

Tremblay G, Deschênes J, Alpert L, Quenneville LA (2005) Overexpression of estrogen receptors in columnar cell change and in unfolding breast lobules. Breast J 11(5):326–332. https://doi.org/10.1111/j.1075-122X.2005.21698.x

Article  CAS  PubMed  Google Scholar 

Speer ME, Huang ML, Dogan BE, Adrada BE, Candelaria RP, Hess KR, Hansakul P, Yang WT, Rauch GM (2018) Rauch GM.High risk breast lesions identified on MRI-guided vacuum-assisted needle biopsy: outcome of surgical excision and imaging follow-up. Br J Radiol 91(1090):20180300. https://doi.org/10.1259/bjr.20180300

Article  PubMed  PubMed Central  Google Scholar 

Okamoto S, Chen ST, Covelli JD, DeMartini WB, Daniel BL, Ikeda DM (2020) High-risk lesions diagnosed at MRI-guided vacuum-assisted breast biopsy: imaging characteristics, outcome of surgical excision or imaging follow-up. Breast Cancer 27(3):405–414. https://doi.org/10.1007/s12282-019-01032-8

Article  PubMed  Google Scholar 

Kuhl CK, Keulers A, Strobel K, Schneider H, Gaisa N, Schrading S (2018) Not all false positive diagnoses are equal: on the prognostic implications of false-positive diagnoses made in breast MRI versus in mammography/digital tomosynthesis screening. Breast Cancer Res 20(1):13. https://doi.org/10.1186/s13058-018-0937-7

Article  PubMed  PubMed Central  Google Scholar 

Heller SL, Elias K, Gupta A, Greenwood HI, Mercado CL, Moy L (2014) Outcome of high-risk lesions at MRI-guided 9-gauge vacuum-assisted breast biopsy. AJR Am J Roentgenol 202(1):237–245. https://doi.org/10.2214/AJR.13.10600

Article  PubMed  Google Scholar 

Linda A, Zuiani C, Furlan A, Lorenzon M, Londero V, Girometti R, Bazzocchi M (2012) Nonsurgical management of high-risk lesions diagnosed at core needle biopsy: can malignancy be ruled out safely with breast MRI? AJR Am J Roentgenol 198(2):272–280. https://doi.org/10.2214/AJR.11.7040

Article  PubMed  Google Scholar 

Martaindale S, Omofoye TS, Teichgraeber DC, Hess KR, Whitman GJ (2020) Imaging follow-up versus surgical excision for radial scars identified on tomosynthesis-guided core needle biopsy. Acad Radiol 27(3):389–394. https://doi.org/10.1016/j.acra.2019.05.012

Article  PubMed  Google Scholar 

Jackman RJ, Nowels KW, Shepard MJ, Finkelstein SI, Marzoni FA Jr (1994) Stereotaxic large-core needle biopsy of 450 nonpalpable breast lesions with surgical correlation in lesions with cancer or atypical hyperplasia. Radiology 193(1):91–95. https://doi.org/10.1148/radiology.193.1.8090927

Article  CAS  PubMed  Google Scholar 

Mooney KL, Bassett LW, Apple SK (2016) Upgrade rates of high-risk breast lesions diagnosed on core needle biopsy: a single-institution experience and literature review. Mod Pathol 29(12):1471–1484. https://doi.org/10.1038/modpathol.2016.127

Article  CAS  PubMed  Google Scholar 

Matar R, Sevilimedu V, Park A, King TA, Pilewskie M (2022) Comparison of outcomes for classic-type lobular carcinoma in situ managed with surgical excision after core biopsy versus observation. Ann Surg Oncol 29(3):1670–1679. https://doi.org/10.1245/s10434-021-10828-y

Article  PubMed  Google Scholar 

Khoury T, Kumar PR, Li Z, Karabakhtsian RG, Sanati S, Chen X, Wang D, Liu S, Reig B (2016) Lobular neoplasia detected in MRI-guided core biopsy carries a high risk for upgrade: a study of 63 cases from four different institutions. Mod Pathol 29(1):25–33. https://doi.org/10.1038/modpathol.2015.128

Article  PubMed  Google Scholar 

Zhong E, Solomon JP, Cheng E, Baum J, Song W, Hoda SA (2020) Apocrine variant of pleomorphic lobular carcinoma in situ: further clinical, histopathologic, immunohistochemical, and molecular characterization of an emerging entity. Am J Surg Pathol 44(8):1092–1103. https://doi.org/10.1097/PAS.0000000000001493

Article  PubMed  Google Scholar 

Sneige N, Wang J, Baker BA, Krishnamurthy S, Middleton LP (2002) Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15(10):1044–1050. https://doi.org/10.1097/01.MP.0000027624.08159.19

Article  PubMed  Google Scholar 

Foschini MP, Miglio R, Fiore R, Baldovini C, Castellano I, Callagy G, Bianchi S, Kaya H, Amendoeira I, Querzoli P, Poli F, Scatena C, Cordoba A, Pietribiasi F, Kovács A, Faistova H, Cserni G, Quinn C (2019) Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature. Eur J Surg Oncol 45(12):2279–2286. https://doi.org/10.1016/j.ejso.2019.07.011

Article  PubMed  Google Scholar 

Lee J, Ku GY, Lee H, Park HS, Ku JS, Kim JY, Park S, Park BW (2022) Lobular carcinoma in situ during preoperative biopsy and the rate of upgrade. Cancer Res Treat 54(4):1074–1080. https://doi.org/10.4143/crt.2021.864

Article  PubMed  Google Scholar 

Kuba MG, Murray MP, Coffey K, Calle C, Morrow M, Brogi E (2021) Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision. Mod Pathol 34(8):1495–1506. https://doi.org/10.1038/s41379-021-00796-9

Article  PubMed  PubMed Central  Google Scholar 

Masannat YA, Husain E, Roylance R, Heys SD, Carder PJ, Ali H, Maurice Y, Pinder SE, Sawyer E, Shaaban AM (2018) Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ. Breast 38:120–124. https://doi.org/10.1016/j.breast.2017.12.011

Article  PubMed  Google Scholar 

Singh K, Paquette C, Kalife ET, Wang Y, Mangray S, Quddus MR, Steinhoff MM (2018) Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes. Hum Pathol 78:163–170. https://doi.org/10.1016/j.humpath.2018.04.026

Article  PubMed  Google Scholar 

Wen HY, Brogi E (2018) Lobular carcinoma in situ. Surg Pathol Clin 11(1):123–145. https://doi.org/10.1016/j.path.2017.09.009

Article  PubMed  Google Scholar 

Schnitt SJ, Brogi E, Chen YY, King TA, Lakhani SR (2020) American Registry of Pathology expert opinions: the Spectrum of lobular carcinoma in situ: diagnostic features and clinical implications. Ann Diagn Pathol 45:151481. https://doi.org/10.1016/j.anndiagpath.2020.151481

Article  PubMed  PubMed Central  Google Scholar 

Katayama A, Toss MS, Parkin M, Ellis IO, Quinn C, Rakha EA (2022) Atypia in breast pathology: what pathologists need to know. Pathology 54(1):20–31. https://doi.org/10.1016/j.pathol.2021.09.008

Article  CAS  PubMed  Google Scholar